Odame, F.;Hosten, E. C.;Tshentu, Z. R. published 《Synthesis,characterization and computational studies of N-[(9E)-8,10,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2,4,6,11(16),12,14-heptaen-9-ylidene] benzamide》 in 2020. The article was appeared in 《Journal of Structural Chemistry》. They have made some progress in their research.SDS of cas: 5805-39-0 The article mentions the following:
N-[(9E)-8,10,17-Triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2,4,6,11(16),12,14-heptaen-9-ylidene] benzamide (I) is synthesized and characterized by spectroscopy, microanal., and single crystal X-ray diffractometry. Compound I crystallizes in the monoclinic space group P21/c with a = 15.8980(7) Å, b = 4.8067(2) Å, c = 21.0455(10) Å, β = 101.153(2)°, and Z = 4. The exptl. bond lengths and bond angles are contrasted with computed bond lengths and bond angles.2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) were involved in the experimental procedure.
2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 SDS of cas: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.
Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem